超声对低疾病活动度类风湿关节炎患者停用TNF抑制剂后预测复发的价值有限
本研究在259例长期低疾病活动度并停用TNF抑制剂的类风湿关节炎患者中,评估超声(US)在临床变量基础上预测52周复发的附加价值。US在组水平可预测复发(多变量风险比=1.7;95%CI:1.1,2.5),但个体预测与未使用US时差异很小(中位差异3.7%;四分位距:-7.8至6.5%),患者水平附加价值有限。
要点
- US在组水平预测停用TNFi后52周复发(HR=1.7;95%CI:1.1,2.5)。
- 个体预测中加入US与未加入US差异小(中位差异3.7%;IQR:-7.8至6.5%)。
- 临床变量已使用时,US对患者水平的预测附加价值有限。
核心结论
- 在长期低疾病活动度RA患者停用TNFi时,US是组水平的复发预测因素,但在患者水平,当已使用常见临床参数时,US的附加价值有限,尽管临床预测因素的预测价值也一般。
研究设计与样本
- 在Potential Optimization of Expediency of TNFi-UltraSonography研究中开发了含与不含US的Cox模型,纳入259例使用TNFi超过1年且联合csDMARD、纳入前6个月DAS28<3.2的RA患者,停用TNFi后随访52周。
主要发现
- US在组水平预测复发(多变量风险比=1.7;95%CI:1.1,2.5)。
- 含与不含US的52周复发个体预测差异很小(中位差异3.7%;四分位距:-7.8至6.5%)。
- 使用US时15.9%患者被归为低风险,未使用时为14.6%。
- 12.0%的患者在不知是否使用US的情况下被US分类为低风险。
关键数值与推荐
- 低风险组定义为<33%复发,中风险组33-50%,高风险组50-100%。
临床怎么用
- 在长期低疾病活动度RA患者停用TNFi的决策中,不应依赖US来显著改善个体水平的复发风险分层。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: Ultrasonography (US) can be used for treatment decisions in RA patients. This study investigated the added value of US to clinical variables in predicting flare in RA patients with longstanding low disease activity when stopping TNF inhibitors (TNFi). METHODS: Cox models with and without using US added to clinical variables were developed in the Potential Optimization of Expediency of TNFi-UltraSonography study. RA patients (n = 259), using >1 year TNFi and csDMARD with DAS28 < 3.2 for 6 months prior to inclusion, were followed for 52 weeks after stopping TNFi. The added value of US was assessed in two ways: first, by the extent to which individual predictions for flare at 52 weeks with and without US differed; and second, by comparing how US information improved the prediction to classify patients at 52 weeks in the low risk (<33% flare), intermediate risk (33-50%) and high risk (50-100%) groups. RESULTS: Although US was predictive of flare at group level (multivariate hazard ratio = 1.7; 95% CI: 1.1, 2.5), individual predictions for flare at 52 weeks with and without US differed little (median difference 3.7%; interquartile range: -7.8 to 6.5%). With US, 15.9% of patients were designated low risk; without US, 14.6%. In fact, 12.0% of patients were US-classified as low risk with/without knowing US. CONCLUSION: In RA patients with longstanding low disease activity, at time of stopping TNFi, US is a predictor for flare at group level, but at the patient level, US has limited added value when common clinical parameters are used already, though the predictive value of clinical predictors is modest as well.
引用
- Lamers-Karnebeek FB, Luime JJ, Ten Cate DF, et al. Limited value for ultrasonography in predicting flare in rheumatoid arthritis patients with low disease activity stopping TNF inhibitors. Rheumatology (Oxford). 2017. PMID: 28595367. doi:10.1093/rheumatology/kex184
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。